title: Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials.
abstract: OBJECTIVE
  To assess the effects of supplementation with oral potassium on blood pressure in humans.
  
  
  METHODS
  Meta-analysis of randomized controlled trials.
  
  
  METHODS
  English-language articles published before July 1995.
  
  
  METHODS
  Thirty-three randomized controlled trials (2609 participants) in which potassium supplementation was the only difference between the intervention and control conditions.
  
  
  METHODS
  Using a standardized protocol, 2 of us independently abstracted information on sample size, duration, study design, potassium dose, participant characteristics, and treatment results.
  
  
  RESULTS
  By means of a random-effects model, findings from individual trials were pooled, after results for each trial were weighted by the inverse of its variance. An extreme effect of potassium in lowering blood pressure was noted in 1 trial. After exclusion of this trial, potassium supplementation was associated with a significant reduction in mean (95% confidence interval) systolic and diastolic blood pressure of -3.11 mm Hg (-1.91 to -4.31 mm Hg) and -1.97 mm Hg (-0.52 to -3.42 mm Hg), respectively. Effects of treatment appeared to be enhanced in studies in which participants were concurrently exposed to a high intake of sodium.
  
  
  CONCLUSIONS
  Our results support the premise that low potassium intake may play an important role in the genesis of high blood pressure. Increased potassium intake should be considered as a recommendation for prevention and treatment of hypertension, especially in those who are unable to reduce their intake of sodium.
authors.affiliation: Welch Center for Prevention, Epidemiology and Clinical Research, The Johns Hopkins University School of Hygiene and Public Health, Baltimore, Md, USA.
authors.forename: P K
authors.initials: PK
authors.lastname: Whelton
authors.forename: J
authors.initials: J
authors.lastname: He
authors.forename: J A
authors.initials: JA
authors.lastname: Cutler
authors.forename: F L
authors.initials: FL
authors.lastname: Brancati
authors.forename: L J
authors.initials: LJ
authors.lastname: Appel
authors.forename: D
authors.initials: D
authors.lastname: Follmann
authors.forename: M J
authors.initials: MJ
authors.lastname: Klag
mesh_terms: D000284:Administration, Oral; D001794:Blood Pressure / Q000187:drug effects*; D005527:Food, Fortified; D006801:Humans; D006973:Hypertension / Q000517:prevention & control; D011188:Potassium / Q000008:administration & dosage / Q000494:pharmacology* / Q000652:urine; D016032:Randomized Controlled Trials as Topic; D012964:Sodium / Q000652:urine; D013223:Statistics as Topic
chemical_list: D012964:Sodium; D011188:Potassium